Karen L. Smith Insider Trading $EBS Emergent BioSolutions Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Karen L. Smith.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Karen L. Smith. Karen L. Smith is Director in ANTARES PHARMA, INC. ($ATRS) and Director in SANGAMO THERAPEUTICS, INC ($SGMO) and EVP, R&D and CMO in Jazz Pharmaceuticals plc ($JAZZ) and Global Head of R&D and CMO in Jazz Pharmaceuticals plc ($JAZZ) and Director in ACCELERON PHARMA INC ($XLRN) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and EVP, Chief Medical Officer in Emergent BioSolutions Inc. ($EBS).

Karen L. Smith in Emergent BioSolutions Inc.

Trading Symbol: EBS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen L. Smith: EVP, Chief Medical Officer
Holdings: 9,252 shares
Current Value: $271,546
Latest Transaction: Feb 26 2021
$EBS Market Capitalization: $1.21B
$EBS Previous Close: $29.35

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Karen L. Smith in Emergent BioSolutions Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, XLRN, ATRS, EBS, JAZZ, SGMO, SCMP

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 26 2021	EBS	Emergent BioSoluti ...	Smith Karen L.	EVP, Chief Medical ...	Option Exercise	A	93.49	11,765	1,099,910	11,765
Feb 26 2021	EBS	Emergent BioSoluti ...	Smith Karen L.	EVP, Chief Medical ...	Grant	A	0.00	2,941	0	12,193	9.3 K to 12.2 K (+31.79 %)
Feb 26 2021	EBS	Emergent BioSoluti ...	Smith Karen L.	EVP, Chief Medical ...	Grant	A	0.00	2,942	0	9,252	6.3 K to 9.3 K (+46.62 %)

Page: 1